DXM and codeine syrup medicine help with symptoms of colds. these medicines can be safe and effective when they are taken as instructed.
The global DXM and Codeine Syrup market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for DXM and Codeine Syrup is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for DXM and Codeine Syrup is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for DXM and Codeine Syrup is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of DXM and Codeine Syrup include Pfizer, Atley Pharmaceuticals, Vertical Pharmaceuticals, Novartis, Merck and Johnson & Johnson, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for DXM and Codeine Syrup, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of DXM and Codeine Syrup, also provides the sales of main regions and countries. Highlights of the upcoming market potential for DXM and Codeine Syrup, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the DXM and Codeine Syrup sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global DXM and Codeine Syrup market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for DXM and Codeine Syrup sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Vertical Pharmaceuticals
Novartis
Merck
Johnson & Johnson
Segment by Type
DXM
Promethazine-codeine Cough Syrup
Segment by Application
Adult
Children
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of DXM and Codeine Syrup in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of DXM and Codeine Syrup manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DXM and Codeine Syrup sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 DXM and Codeine Syrup Product Introduction
1.2 Market by Type
1.2.1 Global DXM and Codeine Syrup Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 DXM
1.2.3 Promethazine-codeine Cough Syrup
1.3 Market by Application
1.3.1 Global DXM and Codeine Syrup Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global DXM and Codeine Syrup Sales Estimates and Forecasts 2019-2030
2.2 Global DXM and Codeine Syrup Revenue by Region
2.2.1 Global DXM and Codeine Syrup Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global DXM and Codeine Syrup Revenue by Region (2019-2024)
2.2.3 Global DXM and Codeine Syrup Revenue by Region (2025-2030)
2.2.4 Global DXM and Codeine Syrup Revenue Market Share by Region (2019-2030)
2.3 Global DXM and Codeine Syrup Sales Estimates and Forecasts 2019-2030
2.4 Global DXM and Codeine Syrup Sales by Region
2.4.1 Global DXM and Codeine Syrup Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global DXM and Codeine Syrup Sales by Region (2019-2024)
2.4.3 Global DXM and Codeine Syrup Sales by Region (2025-2030)
2.4.4 Global DXM and Codeine Syrup Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global DXM and Codeine Syrup Sales by Manufacturers
3.1.1 Global DXM and Codeine Syrup Sales by Manufacturers (2019-2024)
3.1.2 Global DXM and Codeine Syrup Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of DXM and Codeine Syrup in 2023
3.2 Global DXM and Codeine Syrup Revenue by Manufacturers
3.2.1 Global DXM and Codeine Syrup Revenue by Manufacturers (2019-2024)
3.2.2 Global DXM and Codeine Syrup Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by DXM and Codeine Syrup Revenue in 2023
3.3 Global Key Players of DXM and Codeine Syrup, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global DXM and Codeine Syrup Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global DXM and Codeine Syrup Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of DXM and Codeine Syrup, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of DXM and Codeine Syrup, Product Offered and Application
3.8 Global Key Manufacturers of DXM and Codeine Syrup, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global DXM and Codeine Syrup Sales by Type
4.1.1 Global DXM and Codeine Syrup Historical Sales by Type (2019-2024)
4.1.2 Global DXM and Codeine Syrup Forecasted Sales by Type (2025-2030)
4.1.3 Global DXM and Codeine Syrup Sales Market Share by Type (2019-2030)
4.2 Global DXM and Codeine Syrup Revenue by Type
4.2.1 Global DXM and Codeine Syrup Historical Revenue by Type (2019-2024)
4.2.2 Global DXM and Codeine Syrup Forecasted Revenue by Type (2025-2030)
4.2.3 Global DXM and Codeine Syrup Revenue Market Share by Type (2019-2030)
4.3 Global DXM and Codeine Syrup Price by Type
4.3.1 Global DXM and Codeine Syrup Price by Type (2019-2024)
4.3.2 Global DXM and Codeine Syrup Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global DXM and Codeine Syrup Sales by Application
5.1.1 Global DXM and Codeine Syrup Historical Sales by Application (2019-2024)
5.1.2 Global DXM and Codeine Syrup Forecasted Sales by Application (2025-2030)
5.1.3 Global DXM and Codeine Syrup Sales Market Share by Application (2019-2030)
5.2 Global DXM and Codeine Syrup Revenue by Application
5.2.1 Global DXM and Codeine Syrup Historical Revenue by Application (2019-2024)
5.2.2 Global DXM and Codeine Syrup Forecasted Revenue by Application (2025-2030)
5.2.3 Global DXM and Codeine Syrup Revenue Market Share by Application (2019-2030)
5.3 Global DXM and Codeine Syrup Price by Application
5.3.1 Global DXM and Codeine Syrup Price by Application (2019-2024)
5.3.2 Global DXM and Codeine Syrup Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada DXM and Codeine Syrup Market Size by Type
6.1.1 US & Canada DXM and Codeine Syrup Sales by Type (2019-2030)
6.1.2 US & Canada DXM and Codeine Syrup Revenue by Type (2019-2030)
6.2 US & Canada DXM and Codeine Syrup Market Size by Application
6.2.1 US & Canada DXM and Codeine Syrup Sales by Application (2019-2030)
6.2.2 US & Canada DXM and Codeine Syrup Revenue by Application (2019-2030)
6.3 US & Canada DXM and Codeine Syrup Market Size by Country
6.3.1 US & Canada DXM and Codeine Syrup Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada DXM and Codeine Syrup Sales by Country (2019-2030)
6.3.3 US & Canada DXM and Codeine Syrup Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe DXM and Codeine Syrup Market Size by Type
7.1.1 Europe DXM and Codeine Syrup Sales by Type (2019-2030)
7.1.2 Europe DXM and Codeine Syrup Revenue by Type (2019-2030)
7.2 Europe DXM and Codeine Syrup Market Size by Application
7.2.1 Europe DXM and Codeine Syrup Sales by Application (2019-2030)
7.2.2 Europe DXM and Codeine Syrup Revenue by Application (2019-2030)
7.3 Europe DXM and Codeine Syrup Market Size by Country
7.3.1 Europe DXM and Codeine Syrup Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe DXM and Codeine Syrup Sales by Country (2019-2030)
7.3.3 Europe DXM and Codeine Syrup Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China DXM and Codeine Syrup Market Size
8.1.1 China DXM and Codeine Syrup Sales (2019-2030)
8.1.2 China DXM and Codeine Syrup Revenue (2019-2030)
8.2 China DXM and Codeine Syrup Market Size by Application
8.2.1 China DXM and Codeine Syrup Sales by Application (2019-2030)
8.2.2 China DXM and Codeine Syrup Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia DXM and Codeine Syrup Market Size by Type
9.1.1 Asia DXM and Codeine Syrup Sales by Type (2019-2030)
9.1.2 Asia DXM and Codeine Syrup Revenue by Type (2019-2030)
9.2 Asia DXM and Codeine Syrup Market Size by Application
9.2.1 Asia DXM and Codeine Syrup Sales by Application (2019-2030)
9.2.2 Asia DXM and Codeine Syrup Revenue by Application (2019-2030)
9.3 Asia DXM and Codeine Syrup Sales by Region
9.3.1 Asia DXM and Codeine Syrup Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia DXM and Codeine Syrup Revenue by Region (2019-2030)
9.3.3 Asia DXM and Codeine Syrup Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America DXM and Codeine Syrup Market Size by Type
10.1.1 Middle East, Africa and Latin America DXM and Codeine Syrup Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America DXM and Codeine Syrup Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America DXM and Codeine Syrup Market Size by Application
10.2.1 Middle East, Africa and Latin America DXM and Codeine Syrup Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America DXM and Codeine Syrup Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America DXM and Codeine Syrup Sales by Country
10.3.1 Middle East, Africa and Latin America DXM and Codeine Syrup Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America DXM and Codeine Syrup Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America DXM and Codeine Syrup Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer DXM and Codeine Syrup Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Pfizer DXM and Codeine Syrup Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Atley Pharmaceuticals
11.2.1 Atley Pharmaceuticals Company Information
11.2.2 Atley Pharmaceuticals Overview
11.2.3 Atley Pharmaceuticals DXM and Codeine Syrup Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Atley Pharmaceuticals DXM and Codeine Syrup Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Atley Pharmaceuticals Recent Developments
11.3 Vertical Pharmaceuticals
11.3.1 Vertical Pharmaceuticals Company Information
11.3.2 Vertical Pharmaceuticals Overview
11.3.3 Vertical Pharmaceuticals DXM and Codeine Syrup Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Vertical Pharmaceuticals DXM and Codeine Syrup Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Vertical Pharmaceuticals Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis DXM and Codeine Syrup Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novartis DXM and Codeine Syrup Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Overview
11.5.3 Merck DXM and Codeine Syrup Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Merck DXM and Codeine Syrup Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson DXM and Codeine Syrup Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Johnson & Johnson DXM and Codeine Syrup Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 DXM and Codeine Syrup Industry Chain Analysis
12.2 DXM and Codeine Syrup Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 DXM and Codeine Syrup Production Mode & Process
12.4 DXM and Codeine Syrup Sales and Marketing
12.4.1 DXM and Codeine Syrup Sales Channels
12.4.2 DXM and Codeine Syrup Distributors
12.5 DXM and Codeine Syrup Customers
13 Market Dynamics
13.1 DXM and Codeine Syrup Industry Trends
13.2 DXM and Codeine Syrup Market Drivers
13.3 DXM and Codeine Syrup Market Challenges
13.4 DXM and Codeine Syrup Market Restraints
14 Key Findings in The Global DXM and Codeine Syrup Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Pfizer
Atley Pharmaceuticals
Vertical Pharmaceuticals
Novartis
Merck
Johnson & Johnson
听
听
*If Applicable.